With its more than 30 years of experience in the health industry, its commitment at the head of the European diagnostics federation and its outreach and international leadership, Ahimsa Partners offers its contribution to major international organizations, particularly in the context of partnerships with the private sector, which remains a key public health actor. Public-private partnerships and even private-private partnerships must continue to grow to find new models that provide the neediest with better access to healthcare.
Availability of low-cost and robust point-of-care (PoC) diagnostics that are suitable for remote health care centres in low- and middle-income countries (LMICs) would facilitate surveillance and identification of etiological agents as well as guide decisions for treatment, response, and reporting.
Since 2006 UNITAID has, through innovative funding, promoted access to treatment for AIDS, tuberculosis and malaria for the citizens of poor countries. UNITAID negotiates low prices for drugs and diagnostics and improves the accessibility of these products.